Moreover, IHC results showed substantially increased expression of HO-1, ACSL4, NF-κB, and IKKβ in human liver biopsy samples from patients with NASH (Fig. 7A and B). This evidence concerns the gene ACSL4 and metabolic dysfunction-associated steatohepatitis.